Mark Levin

Director, Third Rock Ventures

Mark Levin has more than 36 years of biotech and pharma experience, including 25 years building and operating leading biotech companies. In 2007, he co-founded Third Rock Ventures, where he focuses on the formation, development, and business strategy of its portfolio companies, serving as CEO during their first 12-18 months post-launch. Previously, he co-founded Mayfield Fund’s life sciences effort and was founding CEO and/or board member of its Tularik, Cell Genesys/Abgenix, Focal, Stem Cells, and Millennium Pharmaceuticals companies for 15 years. Earlier in his career, he was an engineer and project leader at Lilly and Genentech. Mark holds an MS degree in chemical and biochemical engineering from Washington University and is a member of the National Academy of Engineering and the Friends of Personalized Medicine. He is co-founder of upSTART, a Cambridge, Mass., after-school program designed to help aspiring young entrepreneurs run their own businesses.